 | Up a level |
Fanale, Michelle, Assouline, Sarit, Kuruvilla, John, Solal-Celigny, Philippe, Heo, Dae S., Verhoef, Gregor, Corradini, Paolo 
ORCID: 0000-0002-9186-1353, Abramson, Jeremy S., Offner, Fritz, Engert, Andreas, Dyer, Martin J. S., Carreon, Daniel, Ewald, Brett, Baeck, Johan, Younes, Anas and Freedman, Arnold S.
(2014).
Phase IA/II, multicentre, open-label study of the CD40 antagonistic monoclonal antibody lucatumumab in adult patients with advanced non-Hodgkin or Hodgkin lymphoma.
Br. J. Haematol., 164 (2).
S. 258 - 266.
HOBOKEN:
WILEY.
ISSN 1365-2141
Freedman, Arnold S., Kuruvilla, John, Assouline, Sarit E., Engert, Andreas, Heo, DaeSeog, Solal-Celigny, Philippe, Corradini, Paolo, Verhoef, Gregor, Fanale, Michelle A., Bendiske, Jennifer, Ewald, Brett, Dey, Jyotirmoy, Baeck, Johan and Younes, Anas (2010). Clinical Activity of Lucatumumab (HCD122) In Patients (pts) with Relapsed/Refractory Hodgkin or Non-Hodgkin Lymphoma Treated In a Phase Ia/II Clinical Trial (NCT00670592). Blood, 116 (21). S. 129 - 130. WASHINGTON: AMER SOC HEMATOLOGY. ISSN 0006-4971